{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:51:49Z","timestamp":1773291109511,"version":"3.50.1"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2013,8,29]],"date-time":"2013-08-29T00:00:00Z","timestamp":1377734400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0073059","type":"journal-article","created":{"date-parts":[[2013,8,29]],"date-time":"2013-08-29T17:10:39Z","timestamp":1377796239000},"page":"e73059","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["The Conformational Control Inhibitor of Tyrosine Kinases DCC-2036 Is Effective for Imatinib-Resistant Cells Expressing T674I FIP1L1-PDGFR\u03b1"],"prefix":"10.1371","volume":"8","author":[{"given":"Yingying","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoke","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingxuan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,8,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-197501000-00001","article-title":"The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature","volume":"54","author":"MJ Chusid","year":"1975","journal-title":"Medicine (Baltimore)"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1158\/1078-0432.CCR-08-1302","article-title":"Alemtuzumab therapy for hypereosinophilic syndrome and chronic eosinophilic leukemia","volume":"15","author":"S Verstovsek","year":"2009","journal-title":"Clin Cancer Res"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"JW Vardiman","year":"2009","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3324\/haematol.2009.016345","article-title":"Screening for diverse PDGFRA or PDGFRB fusion genes is facilitated by generic quantitative reverse transcriptase polymerase chain reaction analysis","volume":"95","author":"P Erben","year":"2010","journal-title":"Haematologica"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1158\/0008-5472.CAN-06-4183","article-title":"Molecular mechanisms underlying FIP1L1-PDGFRA-mediated myeloproliferation","volume":"67","author":"M Buitenhuis","year":"2007","journal-title":"Cancer Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"7719","DOI":"10.1074\/jbc.M807489200","article-title":"FIP1L1-PDGFRalpha imposes eosinophil lineage commitment on hematopoietic stem\/progenitor cells","volume":"284","author":"K Fukushima","year":"2009","journal-title":"J Biol Chem"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Bixby D, Talpaz M (2009) Mechanisms of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and recent therapeutic strategies to overcome resistance. Hematology Am Soc Hematol Educ Program: 461\u2013476.","DOI":"10.1182\/asheducation-2009.1.461"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/leu.2011.181","article-title":"Limited clinical activity of nilotinib and sorafenib in FIP1L1-PDGFRA positive chronic eosinophilic leukemia with imatinib-resistant T674I mutation","volume":"26","author":"G Metzgeroth","year":"2012","journal-title":"Leukemia"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1158\/0008-5472.CAN-10-3224","article-title":"The ABL switch control inhibitor DCC-2036 is active against the chronic myeloid leukemia mutant BCR-ABLT315I and exhibits a narrow resistance profile","volume":"71","author":"CA Eide","year":"2011","journal-title":"Cancer Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.ccr.2011.03.003","article-title":"Conformational control inhibition of the BCR-ABL1 tyrosine kinase, including the gatekeeper T315I mutant, by the switch-control inhibitor DCC-2036","volume":"19","author":"WW Chan","year":"2011","journal-title":"Cancer Cell"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1158\/1535-7163.MCT-09-0468","article-title":"The antitumor activity of homoharringtonine against human mast cells harboring the KIT D816V mutation","volume":"9","author":"Y Jin","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1158\/1078-0432.CCR-08-2141","article-title":"Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation","volume":"15","author":"X Shi","year":"2009","journal-title":"Clin Cancer Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa025217","article-title":"A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome","volume":"348","author":"J Cools","year":"2003","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1182\/blood-2003-07-2479","article-title":"The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia","volume":"103","author":"J Cools","year":"2004","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1158\/1078-0432.CCR-11-1971","article-title":"Cyclin-dependent kinase 7\/9 inhibitor SNS-032 abrogates FIP1-like-1 platelet-derived growth factor receptor alpha and bcr-abl oncogene addiction in malignant hematologic cells","volume":"18","author":"Y Wu","year":"2012","journal-title":"Clin Cancer Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1210\/jcem.86.10.7860","article-title":"Cytochrome c release is upstream to activation of caspase-9, caspase-8, and caspase-3 in the enhanced apoptosis of anaplastic thyroid cancer cells induced by manumycin and paclitaxel","volume":"86","author":"J Pan","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1158\/0008-5472.CAN-04-2744","article-title":"Farnesyltransferase inhibitors induce DNA damage via reactive oxygen species in human cancer cells","volume":"65","author":"J Pan","year":"2005","journal-title":"Cancer Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1111\/j.1349-7006.2009.01283.x","article-title":"Triptolide abrogates oncogene FIP1L1-PDGFRalpha addiction and induces apoptosis in hypereosinophilic syndrome","volume":"100","author":"Y Jin","year":"2009","journal-title":"Cancer Sci"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.cell.2012.02.065","article-title":"The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis","volume":"149","author":"CH Chan","year":"2012","journal-title":"Cell"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1126\/science.1175065","article-title":"The E3 ligase TRAF6 regulates Akt ubiquitination and activation","volume":"325","author":"WL Yang","year":"2009","journal-title":"Science"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.canlet.2009.09.006","article-title":"Celastrol, a novel HSP90 inhibitor, depletes Bcr-Abl and induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation","volume":"290","author":"Z Lu","year":"2010","journal-title":"Cancer Lett"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.drup.2005.04.005","article-title":"Resistance to tyrosine kinase inhibitors: calling on extra forces","volume":"8","author":"J Cools","year":"2005","journal-title":"Drug Resist Updat"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1182\/blood-2006-02-004457","article-title":"Sorafenib is a potent inhibitor of FIP1L1-PDGFRalpha and the imatinib-resistant FIP1L1-PDGFRalpha T674I mutant","volume":"108","author":"E Lierman","year":"2006","journal-title":"Blood"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/sj.cdd.4401596","article-title":"Cytochrome c is released in a single step during apoptosis","volume":"12","author":"JC Goldstein","year":"2005","journal-title":"Cell Death Differ"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Kole AJ, Knight ER, Deshmukh M (2011) Activation of apoptosis by cytoplasmic microinjection of cytochrome c. J Vis Exp.","DOI":"10.3791\/2773"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e294","DOI":"10.1371\/journal.pmed.0040294","article-title":"Induction of BIM is essential for apoptosis triggered by EGFR kinase inhibitors in mutant EGFR-dependent lung adenocarcinomas","volume":"4","author":"Y Gong","year":"2007","journal-title":"PLoS Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"14109","DOI":"10.1074\/jbc.M109.078592","article-title":"Role for the proapoptotic factor BIM in mediating imatinib-induced apoptosis in a c-KIT-dependent gastrointestinal stromal tumor cell line","volume":"285","author":"PM Gordon","year":"2010","journal-title":"J Biol Chem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/emboj\/17.2.384","article-title":"Bim: a novel member of the Bcl-2 family that promotes apoptosis","volume":"17","author":"L O'Connor","year":"1998","journal-title":"EMBO J"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1038\/sj.onc.1208421","article-title":"Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cells","volume":"24","author":"A Essafi","year":"2005","journal-title":"Oncogene"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.molcel.2008.03.025","article-title":"Multisite phosphorylation regulates Bim stability and apoptotic activity","volume":"30","author":"A Hubner","year":"2008","journal-title":"Mol Cell"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1038\/sj.onc.1206792","article-title":"Phosphorylation of Bim-EL by Erk1\/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function","volume":"22","author":"F Luciano","year":"2003","journal-title":"Oncogene"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/leu.2009.2","article-title":"FIP1L1-PDGFRalpha D842V, a novel panresistant mutant, emerging after treatment of FIP1L1-PDGFRalpha T674I eosinophilic leukemia with single agent sorafenib","volume":"23","author":"E Lierman","year":"2009","journal-title":"Leukemia"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/sj.leu.2403600","article-title":"Myeloid blast crisis evolving during imatinib treatment of an FIP1L1-PDGFR alpha-positive chronic myeloproliferative disease with prominent eosinophilia","volume":"19","author":"N von Bubnoff","year":"2005","journal-title":"Leukemia"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1398-9995.2009.01943.x","article-title":"A novel FIP1L1-PDGFRA mutant destabilizing the inactive conformation of the kinase domain in chronic eosinophilic leukemia\/hypereosinophilic syndrome","volume":"64","author":"S Salemi","year":"2009","journal-title":"Allergy"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.canlet.2008.07.040","article-title":"Combination of imatinib and vinorelbine enhances cell growth inhibition in breast cancer cells via PDGFR beta signalling","volume":"273","author":"MT Weigel","year":"2009","journal-title":"Cancer Lett"},{"key":"ref36","first-page":"2169","article-title":"Combination treatment of imatinib-sensitive and -resistant BCR-ABL-positive CML cells with imatinib and farnesyltransferase inhibitors","volume":"26","author":"A Radujkovic","year":"2006","journal-title":"Anticancer Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1158\/1078-0432.CCR-09-3314","article-title":"Targeting the BCR-ABL signaling pathway in therapy-resistant Philadelphia chromosome-positive leukemia","volume":"17","author":"T O'Hare","year":"2011","journal-title":"Clin Cancer Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1182\/blood-2009-11-251751","article-title":"Discovery of a small-molecule type II inhibitor of wild-type and gatekeeper mutants of BCR-ABL, PDGFRalpha, Kit, and Src kinases: novel type II inhibitor of gatekeeper mutants","volume":"115","author":"E Weisberg","year":"2010","journal-title":"Blood"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0073059","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T19:55:02Z","timestamp":1540497302000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0073059"}},"subtitle":[],"editor":[{"given":"Carolyn J.","family":"Baglole","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,8,29]]},"references-count":38,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,8,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0073059","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,29]]}}}